S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

CNTX Context Therapeutics Inc

1.84

0.00 (0.00%)

Nov 17 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics Inc News

Form EFFECT - Notice of Effectiveness
Thursday 14 November 2024 (3 days ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (3 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results
Wednesday 6 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Context Therapeutics to Participate in Upcoming Investor Conferences in November
Wednesday 23 October 2024 (4 weeks ago) • GlobeNewswire Inc.

Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Wednesday 16 October 2024 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 23 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 September 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 4 September 2024 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors
Wednesday 4 September 2024 (2 months ago) • GlobeNewswire Inc.

Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results
Wednesday 7 August 2024 (3 months ago) • GlobeNewswire Inc.

More Context Therapeutics Inc News Articles

Context Therapeutics

Entourage Health

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions